| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2010.03.032 |
| P698 | PubMed publication ID | 20362203 |
| P50 | author | Jun Chang | Q56754401 |
| P2093 | author name string | Jae-Rang Yu | |
| Sol Kim | |||
| Ji-Eun Jang | |||
| P2860 | cites work | A simplified system for generating recombinant adenoviruses | Q24682328 |
| Development of a preventive vaccine for Ebola virus infection in primates | Q28140401 | ||
| Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection | Q30308018 | ||
| Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection | Q30442832 | ||
| Respiratory syncytial virus genetic and antigenic diversity | Q33812405 | ||
| Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion | Q33934074 | ||
| Role of secretory antibodies in the defence against infections | Q35130615 | ||
| Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge | Q35149731 | ||
| Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model | Q36003444 | ||
| Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection | Q36483809 | ||
| Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. | Q36920250 | ||
| Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity | Q37401975 | ||
| Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus. | Q37452172 | ||
| Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus | Q39106556 | ||
| Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture | Q39684652 | ||
| Immunopathogenesis of vaccine-enhanced RSV disease. | Q40595357 | ||
| Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein | Q40983230 | ||
| CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells | Q41622552 | ||
| Protection against respiratory syncytial virus infection by DNA immunization | Q41907861 | ||
| Impact of respiratory virus infections on persons with chronic underlying conditions | Q45256053 | ||
| Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice | Q45386439 | ||
| Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant | Q45391143 | ||
| Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus. | Q45400356 | ||
| Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus | Q45600695 | ||
| Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity | Q45734062 | ||
| DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation | Q45740607 | ||
| Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H. | Q45742833 | ||
| Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden | Q45752482 | ||
| Respiratory syncytial virus infection in older persons | Q45753399 | ||
| Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. | Q45776121 | ||
| Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit | Q45780126 | ||
| Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model | Q45780249 | ||
| Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen | Q45831199 | ||
| Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines | Q45849052 | ||
| Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen | Q47783342 | ||
| Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza | Q68621446 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| immunization | Q1415366 | ||
| P304 | page(s) | 3801-3808 | |
| P577 | publication date | 2010-03-31 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection | |
| P478 | volume | 28 |
| Q38130514 | Advances in and the potential of vaccines for respiratory syncytial virus |
| Q35595950 | An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children |
| Q40880160 | Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection |
| Q26775152 | Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease |
| Q37849858 | Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection |
| Q37713960 | Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model |
| Q34258568 | Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotides |
| Q40187606 | Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate. |
| Q39436774 | Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands |
| Q45179251 | Induction of mucosal immunity by intranasal immunization with recombinant adenovirus expressing major epitopes of Porcine circovirus-2 capsid protein |
| Q36937656 | Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice |
| Q35005641 | Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection |
| Q37857851 | Opportunities and challenges of the pulmonary route for vaccination |
| Q34701517 | Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. |
| Q41995734 | Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR. |
| Q56893551 | Respiratory syncytial virus vaccine development |
| Q39534390 | Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration. |
| Q37328584 | Targeting RSV with vaccines and small molecule drugs |
| Q38068469 | The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development. |
| Q42732044 | Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice |
Search more.